Opella

Transaction overview

Status: Announced

Exact closing date not established.

Sanofi and CD&R announced on February 19, 2025 that they had signed a share purchase agreement for CD&R to acquire a 50% controlling stake in Opella. Sanofi would remain a significant shareholder, and Bpifrance was expected to hold approximately 2%. Closing remained subject to regulatory approvals and was expected no earlier than the second quarter of 2025; an actual closing date was not reported.

Selected source-supported transactions; coverage is incomplete. Announcements do not establish completion or that a deal is still pending. Sponsor activity and operating-business transactions are distinct from adviser acquisitions. Unclassified activity is excluded from adviser-only counts.